Amoxicillin/AmoxiClav Generics
Bacterial Infections
ApprovedActive
Key Facts
About Puren Pharmaceuticals
Puren Pharma is a privately-held, commercial-stage generic drug company based in Munich, Germany. It operates a hybrid business model, combining the development and supply of generic pharmaceuticals (e.g., antibiotics like Amoxicillin) with a portfolio of branded consumer health products. The company emphasizes values of responsibility, sustainability, and partnership, and is actively involved in humanitarian aid efforts. Its strategic focus appears to be on ensuring supply of essential medicines while expanding its branded over-the-counter offerings.
View full company profileTherapeutic Areas
Other Bacterial Infections Drugs
| Drug | Company | Phase |
|---|---|---|
| Generic Portfolio Expansion - Anti-infectives | Alkaloid AD Skopje | Regulatory Submission |
| Vibativ® (telavancin) | Cleo Life Sciences | Approved |
| Penicillin V API | Biotika | Commercial |
| Sterile Injectable Antibiotics Portfolio | Steripharma | Approved |
| Oral Antibiotic | Dawah Pharmaceuticals | ANDA Filed/Pre-approval |
| XAB05/XAB06 | Xenothera | Preclinical |
| Antibacterial Program | Prosetta Biosciences | Preclinical |
| Novel Antibiotic Class 1 | ArrePath | Pre-clinical |
| Novel Antibiotic Class 2 | ArrePath | Pre-clinical |
| Ready-to-Use Antibiotics in Bags | Galenica Senese | Commercial |
| Lasvic (Lascufloxacin) | KYORIN Pharmaceutical | Marketed |
| Anti-infective Candidate(s) | China Resources Pharmaceutical Group | Phase II / Phase III |